Stay updated with breaking news from Stephen Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
London, UK - 3 November 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental
London, UK 3 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced it will be conducting a phase II clinical trial to assess the safety and tolerability of COMP360 psilocybin therapy in post-traumatic stress disorder . The study expands COMPASS’s research pipeline in psilocybin therapy with COMP360, ...
Investegate announcements from COMPASS Pathways, Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups
Investigator-initiated study shows remission in major depression symptoms for 50% of participants London, UK 20 October 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed the topline data shared today from an open-label study of psilocybin therapy for depression in cancer patients. Within one week of a single ...
Investegate announcements from COMPASS Pathways, COMPASS Pathways is granted new US patent for crystalline psilocybin